Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2021). Universal Coronavirus Vaccines—An Urgent Need. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2118468

Lipsitch, M., Krammer, F., Regev-Yochay, G., Lustig, Y., & Balicer, R. D. (2021). SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact. Nature Reviews Immunology, 1–9. https://doi.org/10.1038/s41577-021-00662-4

Mia Malan. (2021, November 25). [Thread] What is the potential impact of the new B.1.1.529 #COVID19 variant? @rjlessells: 1. It’s relatively simple to detect some B.1.1.529 cases, as it’s possible to use PCR tests to do this in some cases 2. B.1.1.529 = has many mutations across different parts of the virus https://t.co/ytktqLzJUi [Tweet]. @miamalan. https://twitter.com/miamalan/status/1463846528578109444

Living with COVID-19: How the virus could turn into the common cold, or something far worse. (2022, January 9). The Mercury News. https://www.mercurynews.com/2022/01/09/living-with-covid-19-how-the-virus-could-turn-into-the-common-cold-or-something-far-worse

Geddes, L., & correspondent, L. G. S. (2022, January 11). Will Covid-19 become less dangerous as it evolves? The Guardian. https://www.theguardian.com/world/2022/jan/11/will-covid-19-become-less-dangerous-as-it-evolves

Yonker, L. M., Boucau, J., Regan, J., Choudhary, M. C., Burns, M. D., Young, N., Farkas, E. J., Davis, J. P., Moschovis, P. P., Bernard Kinane, T., Fasano, A., Neilan, A. M., Li, J. Z., & Barczak, A. K. (2021). Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. The Journal of Infectious Diseases, 224(11), 1821–1829. https://doi.org/10.1093/infdis/jiab509

Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5

Singanayagam, A., Hakki, S., Dunning, J., Madon, K. J., Crone, M. A., Koycheva, A., Derqui-Fernandez, N., Barnett, J. L., Whitfield, M. G., Varro, R., Charlett, A., Kundu, R., Fenn, J., Cutajar, J., Quinn, V., Conibear, E., Barclay, W., Freemont, P. S., Taylor, G. P., … Lackenby, A. (2021). Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00648-4

Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology (Cambridge, Mass.), 32(6), 820–828. https://doi.org/10.1097/EDE.0000000000001415

Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K., Walker, A. S., & Peto, T. E. (2021). The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission (p. 2021.09.28.21264260). https://doi.org/10.1101/2021.09.28.21264260

Lee Kennedy-Shaffer. (2021, May 6). .@rebeccajk13 and @mlipsitch showed how to use that to estimate efficacy against prevalent infection (https://t.co/LeXxqcumGS). [Tweet]. @LeeKShaffer. https://twitter.com/LeeKShaffer/status/1390322501817880581

Reardon, S. (2021). How the Delta variant achieves its ultrafast spread. Nature. https://doi.org/10.1038/d41586-021-01986-w

Lipsitch, M., & Kahn, R. (2021). Interpreting vaccine efficacy trial results for infection and transmission. Vaccine, 39(30), 4082–4088. https://doi.org/10.1016/j.vaccine.2021.06.011

More transmissible variant makes vaccinations more crucial, experts say. (2021, June 10). STAT. https://www.statnews.com/2021/06/10/more-transmissible-variant-covid-19-vaccinations-even-more-crucial/

Feng, L., Zhang, T., Wang, Q., Xie, Y., Peng, Z., Zheng, J., Qin, Y., Zhang, M., Lai, S., Wang, D., Feng, Z., Li, Z., & Gao, G. F. (2021). Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nature Communications, 12(1), 3249. https://doi.org/10.1038/s41467-021-23440-1

García-Fiñana, M., & Buchan, I. E. (2021). Rapid antigen testing in COVID-19 responses. Science, 372(6542), 571–572. https://doi.org/10.1126/science.abi6680

Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00262-0

Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating vaccine efficacy against transmission via effect on viral load [Preprint]. Infectious Diseases (except HIV/AIDS). https://doi.org/10.1101/2021.05.03.21256556

Kissler, S., Fauver, J. R., Mack, C., Tai, C. G., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Ho, D. D., Grubaugh, N. D., & Grad, Y. (2021). Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. https://dash.harvard.edu/handle/1/37366884

Diseases, T. L. I. (2021). An exceptional vaccination policy in exceptional circumstances. The Lancet Infectious Diseases, 21(2), 149. https://doi.org/10.1016/S1473-3099(21)00008-6

Parker-Pope, T. (2021, April 22). Do We Still Need to Keep Wearing Masks Outdoors? The New York Times. https://www.nytimes.com/2021/04/22/well/live/covid-masks-outdoors.html?smid=tw-share

Covid Data Science. (2021) ‘UK Variant B.1.1.7 becoming the dominant strain in the USA - what does it mean for Spring/Summer?’. Accessed 26 March 2021. https://www.covid-datascience.com/post/uk-variant-b-1-1-7-becoming-the-dominant-strain-in-the-usa-what-does-it-mean-for-spring-summer

A Marm Kilpatrick. (2021, February 9). Vaccine efficacy in blocking infection & transmission (I think) We can now estimate the (minimum) reduction in transmission from the Moderna vaccine. Thread tl;dr Moderna vaccine blocks >90% (87-93%) of infections & 91% (89-94%) of transmission. *Critiques welcome! Https://t.co/GjQIo3v4oe [Tweet]. @DiseaseEcology. https://twitter.com/DiseaseEcology/status/1359213735424872450

Bosco-Lauth, A. M., Hartwig, A. E., Porter, S. M., Gordy, P. W., Nehring, M., Byas, A. D., VandeWoude, S., Ragan, I. K., Maison, R. M., & Bowen, R. A. (2020). Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2013102117

Mondelli, Mario U., Marta Colaneri, Elena M. Seminari, Fausto Baldanti, and Raffaele Bruno. ‘Low Risk of SARS-CoV-2 Transmission by Fomites in Real-Life Conditions’. The Lancet Infectious Diseases 0, no. 0 (29 September 2020). https://doi.org/10.1016/S1473-3099(20)30678-2.

Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4

Virus transmission from urinals. (2020). Physics of Fluids, 32(8), 081703. https://doi.org/10.1063/5.0021450

The tricks of using an aeroplane toilet and other ways to reduce your COVID risk while flying. (2020, August 28). https://www.abc.net.au/news/health/2020-08-29/coronavirus-transmission-flights/12593970

Zhang, Q., Honko, A., Zhou, J., Gong, H., Downs, S. N., Vasquez, J. H., Fang, R. H., Gao, W., Griffiths, A., & Zhang, L. (2020). Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Letters. https://doi.org/10.1021/acs.nanolett.0c02278

Lednicky, J. A., Lauzardo, M., Fan, Z. H., Jutla, A. S., Tilly, T. B., Gangwar, M., Usmani, M., Shankar, S. N., Mohamed, K., Eiguren-Fernandez, A., Stephenson, C. J., Alam, M. M., Elbadry, M. A., Loeb, J. C., Subramaniam, K., Waltzek, T. B., Cherabuddi, K., Morris, J. G., & Wu, C.-Y. (2020). Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. MedRxiv, 2020.08.03.20167395. https://doi.org/10.1101/2020.08.03.20167395

Heald-Sargent, T., Muller, W. J., Zheng, X., Rippe, J., Patel, A. B., & Kociolek, L. K. (2020). Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19). JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2020.3651

Natalie E. Dean, PhD on Twitter: “Thanks, @MelissaKariWard, for capturing the since deleted tweets. This is why I expressed concern.” / Twitter. (n.d.). Twitter. Retrieved August 2, 2020, from https://twitter.com/nataliexdean/status/1285033748283654146

Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Painter, C. D., Thacker, B. E., Glass, C. A., Narayanan, A., Majowicz, S. A., Zhang, Y., Torres, J. L., Golden, G. J., Porell, R., Garretson, A. F., Laubach, L., Feldman, J., Yin, X., Pu, Y., Hauser, B., … Esko, J. D. (2020). SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. BioRxiv, 2020.07.14.201616. https://doi.org/10.1101/2020.07.14.201616

Zhang, L., Jackson, C. B., Mou, H., Ojha, A., Rangarajan, E. S., Izard, T., Farzan, M., & Choe, H. (2020). The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. BioRxiv, 2020.06.12.148726. https://doi.org/10.1101/2020.06.12.148726

Sapoval, N., Mahmoud, M., Jochum, M. D., Liu, Y., Elworth, R. A. L., Wang, Q., Albin, D., Ogilvie, H., Lee, M. D., Villapol, S., Hernandez, K., Berry, I. M., Foox, J., Beheshti, A., Ternus, K., Aagaard, K. M., Posada, D., Mason, C., Sedlazeck, F. J., & Treangen, T. J. (2020). Hidden genomic diversity of SARS-CoV-2: Implications for qRT-PCR diagnostics and transmission. BioRxiv, 2020.07.02.184481. https://doi.org/10.1101/2020.07.02.184481

DELVE group publishes evidence paper on the use of face masks in tackling Coronavirus (COVID-19) pandemic | Royal Society. (2020 May 04). https://royalsociety.org/news/2020/05/delve-group-publishes-evidence-paper-on-use-of-face-masks/

Balloux, F. (2020, May 22) A thread written by @BallouxFrancois. Threader. https://threader.app/thread/1263745877702737920

Danis, K., Epaulard, O., Bénet, T., Gaymard, A., Campoy, S., Bothelo-Nevers, E., Bouscambert-Duchamp, M., Spaccaferri, G., Ader, F., Mailles, A., Boudalaa, Z., Tolsma, V., Berra, J., Vaux, S., Forestier, E., Landelle, C., Fougere, E., Thabuis, A., Berthelot, P., … Bag, B. C. (2020). Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clinical Infectious Diseases, ciaa424. https://doi.org/10.1093/cid/ciaa424

Davis, N. (2020, May 4). Report on face masks’ effectiveness for Covid-19 divides scientists. The Guardian. https://www.theguardian.com/world/2020/may/04/scientists-disagree-over-face-masks-effect-on-covid-19

Inglesby, T. V. (2020). Public Health Measures and the Reproduction Number of SARS-CoV-2. JAMA. https://doi.org/10.1001/jama.2020.7878

Lohse, S., Pfuhl, T., Berkó-Göttel, B., Rissland, J., Geißler, T., Gärtner, B., Becker, S. L., Schneitler, S., & Smola, S. (2020). Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. The Lancet Infectious Diseases, S1473309920303625. https://doi.org/10.1016/S1473-3099(20)30362-5

Wölfel, R., Corman, V.M., Guggemos, W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature (2020). https://doi.org/10.1038/s41586-020-2196-x